Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for Disease ...

Dr Dan Hodgkiss, Professor Ian Boardley and Dr Tom Nightingale discuss why parasport needs to act now on electroceuticals ...

Explore the Q4 2025 Alger Weatherbie Specialized Growth Fund performance. Read about the top contributors and detractors in ...

Discover how smart rings 2026 track sleep, HRV, and fitness metrics. Compare Oura Ring 4, accuracy rates, battery life, and ...

The crash looked season-ending, maybe career-ending. On January 30th, Lindsey Vonn wiped out just seconds into her downhill ...

Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for Disease Control and Prevention (CDC ...

HBV coinfection with acute exacerbation was associated with significantly worse survival outcomes in pediatric T-ALL.

REGENXBIO Inc. (Nasdaq: RGNX) today announced that the U.S. Food and Drug Administration (FDA) placed a clinical hold on its investigational gene therapy, RGX-111, for the treatment of MPS I, also ...

Clear Street kept a 'Buy' rating, cut its price target to $45 from $50, and said its core thesis remains intact. ・The FDA ...

New data suggest that faster sodium correction in severe hyponatremia may reduce mortality and delay neurologic events, ...

REGENXBIO Inc.  today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its Biologics License Application (BLA) for RGX-121 (clemidsogene ...

For years, clinicians have noticed that people living with major depression often show unexpectedly fragile bones. What ...